Identification

Nome strumento
ADOCIA
Ticker
ADOC
Codice ISIN
FR0011184241
Mercato
Euronext
Borsa
Paris
Products family
Stocks
ICB
Biotechnology
Activity description

Adocia specializes in the research and development of biotherapy products used in tissue regeneration and for treating chronic diseases.
At the end of June 2011, the group had a portfolio of 4 products in clinical development (including two in phase 2; PDGF-BB, for treating diabetic foot ulcers, and HinsBet, quick-acting human insulin for treating diabetes). 

Indirizzo web
www.adocia.com

Operation

Data IPO
Lun 20/02/2012
Tipologia IPO

Initial Public Offering 

Tipologia IPO
Initial Public offering
Categoria
IPO
Calendario

LISTING DATE: 14/02/2012
TRADING DATE:  20/02/2012  

Intervallo di prezzo
Indicative price range for the Offer: EUR 13.00 - EUR 15.88 ("The Offering Price")